Kolexia
Probst Vincent
Cardiologie
Hôpital Laennec
Saint-Herblain, France
354 Activités
13 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndrome de Brugada Troubles du rythme cardiaque Mort subite cardiaque Syndrome du QT long Mort subite Tachycardie ventriculaire Tachycardie Fibrillation ventriculaire Cardiomyopathies

Industries

Boston Scientific
63 collaboration(s)
Dernière en 2023
Amicus Therapeutics
14 collaboration(s)
Dernière en 2022
Sanofi
6 collaboration(s)
Dernière en 2023
Bayer
4 collaboration(s)
Dernière en 2020

Dernières activités

Enlighten Study: The EV-ICD Post Approval Registry
Essai Clinique (Medtronic)   20 mars 2024
When to ablate in Brugada and early repolarization syndromes.
Expert review of cardiovascular therapy   07 mars 2024
Insights into adherence to medication and lifestyle recommendations in an international cohort of patients with catecholaminergic polymorphic ventricular tachycardia.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology   26 février 2024
The predictive value of the PRAETORIAN score for defibrillation test success in subcutaneous ICD patients: a sub-analysis of the PRAETORIAN-DFT trial.
Heart rhythm   07 février 2024
Pre-emptive treatment of heart failure exacerbations in patients managed with the HeartLogic™ algorithm.
ESC heart failure   17 janvier 2024
Clinical Management of Brugada Syndrome: Commentary From the Experts.
Circulation. Arrhythmia and electrophysiology   15 décembre 2023
Type 3 long QT syndrome: is the effectiveness of treatment with beta-blockers population-specific?
Heart rhythm   11 novembre 2023
Time to consider catheter ablation as an alternative to ICD therapy in high risk patients with brugada syndrome?
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology   09 novembre 2023
An online international survey study into the incidence and potential reasons of therapy non-adherence in catecholaminergic polymorphic ventricular tachycardia: preliminary results
ESC Congress 2023 25–28 August 2023 Amsterdam, Netherlands Abstract Supplement   09 novembre 2023
Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.
Circulation   27 octobre 2023